Judge Dismisses Fosamax Case

Law360, New York (April 11, 2007, 12:00 AM EDT) -- A federal judge said Tuesday that he will allow Merck & Co. to drop a patent infringement suit it filed to stop Canadian generic drug manufacturer Apotex Inc. from launching a generic equivalent of its osteoporosis drug Fosamax.

Judge Gregory M. Sleet of the U.S. District Court for the District of Delaware issued a one-page order to allow the dismissal. He said he would later issue a memorandum and order.

Apotex had opposed Merck’s move to dismiss, saying it was a tactic to keep its product...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.